Invesco Pharmaceuticals ETF
PJP
PJP
96 hedge funds and large institutions have $152M invested in Invesco Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 37 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.87% less ownership
Funds ownership: 16.85% → 14.98% (-1.9%)
21% less capital invested
Capital invested by funds: $194M → $152M (-$41.4M)
27% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 37
Holders
96
Holding in Top 10
2
Calls
$782K
Puts
$306K
Top Buyers
| 1 | +$3.31M | |
| 2 | +$2.11M | |
| 3 | +$741K | |
| 4 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$740K |
| 5 |
SG Americas Securities
New York
|
+$735K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$5.41M | |
| 3 | -$4.39M | |
| 4 |
Goldman Sachs
New York
|
-$3.78M |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
-$3.08M |